Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel asymmetric catalytic synthesis of chiral nitrogen-bridged rings. High stereoselectivity, scalable process for pharmaceutical intermediates and supply chain reliability.
Novel copper-catalyzed asymmetric propargyl substitution method ensures high ee and scalable production for pharmaceutical intermediates.
Patent CN109810125A reveals aqueous Henry reaction breakthrough enabling cost reduction in pharmaceutical intermediates manufacturing with high-purity pharmaceutical intermediates.
Novel chiral intermediate synthesis for Moxifloxacin. High purity, scalable process, cost-effective manufacturing solution for global supply chains.
Patent CN111732600A reveals a stable cuprous complex enabling mild, one-pot benzimidazole synthesis. Discover cost-effective manufacturing solutions.
Patent CN111943980B reveals a green B(C6F5)3-catalyzed synthesis of allyl phosphorus compounds, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN111943980B reveals a green synthesis route for allyl phosphorus compounds using tris(pentafluorophenyl)borane, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN111943980B details a green B(C6F5)3 catalyzed synthesis of allyl phosphorus compounds, offering cost reduction in pharmaceutical intermediates manufacturing.
Patent CN105017150A details a palladium-catalyzed asymmetric hydrogenation method for high-purity chiral exocyclic amines, offering significant supply chain and cost advantages.
Patent CN115385920A details a scalable BTK inhibitor refining method achieving 99.4% purity without column chromatography, offering significant cost reduction in API manufacturing.
Patent CN109180682A reveals a proline-based route for bicyclic NHC precursors, offering streamlined synthesis and enhanced supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN107253967A enables transition-metal-free silylation for high-purity pharmaceutical intermediates. Achieve substantial cost reduction and supply chain reliability.
Novel cesium carbonate catalyzed route offers high yield and mild conditions for pharmaceutical intermediate manufacturing supply chain optimization.
Patent CN106187855B reveals a one-step green synthesis for 2-aryl indoles. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101717386A reveals solid superacid catalyst for high-yield coumarin synthesis. Reduces waste and equipment corrosion for reliable supply chain.
Novel synthesis method for fluorinated intermediates reduces costs and improves supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN104130190B reveals ionic liquid catalyst microwave synthesis. High purity, reusable catalyst, water solvent reduces cost and environmental impact for supply chains.
Patent CN116987136B reveals ionic liquid method for high-yield UTP. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Novel ionic liquid catalysis enables high-purity monomer production with reduced waste and enhanced supply chain reliability for polymer manufacturers.
Patent CN1063491C details a low-temperature enzymatic route for cephalosporins, offering reduced byproducts and simplified pH control for scalable manufacturing.